Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00895-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Fangfang Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Macao Polytechnic University, Guizhou Provincial Basic Research Program.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) acquires high-level resistance against β-lactam antibiotics by expressing penicillin-binding protein 2a (PBP2a). PBP2a is a cell wall-synthesizing protein whose closed active site exhibits a reduced binding affinity toward β-lactam antibiotics. Ceftaroline (CFT), a fifth-generation cephalosporin, can effectively inhibit the PBP2a activity by binding to an allosteric site to trigger the active site opening, allowing a second CFT to access the active site. However, the essential mechanism behind the allosteric behavior of PBP2a remains unclear. Herein, computational simulations are employed to elucidate how CFT allosterically regulates the conformation and dynamics of the active site of PBP2a. While CFT stabilizes the allosteric domain surrounding it, it simultaneously enhances the dynamics of the catalytic domain. Specifically, the study successfully captured the opening process of the active pocket in the allosteric CFT-bound systems and discovered that CFT alters the potential signal-propagating pathways from the allosteric site to the active site. These findings reveal the implied mechanism of the CFT-mediated allostery in PBP2a and provide new insights into dual-site drug design or combination therapy against MRSA targeting PBP2a.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
- College of Life Sciences, Nanjing Agricultural University, Nanjing, China.
- School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
- Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Fangfang Jiao, Jingjing Guo
Förderung
- Macao Polytechnic University
- Guizhou Provincial Basic Research Program
Zitieren
APA
Jiao, F., Bao, Y., Li, M., Zhang, Y., Zhang, F., Wang, P., Tao, J., Tong, H. H. Y., & Guo, J. (2023). Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00895-23
Vancouver
Jiao F, Bao Y, Li M, Zhang Y, Zhang F, Wang P, et al. Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00895-23
BibTeX
@article{Jiao2023,
author = {Jiao, Fangfang and Bao, Yiqiong and Li, Mengrong and Zhang, Yan and Zhang, Feng and Wang, Pinkai and Tao, Jun and Tong, Henry H Y and Guo, Jingjing},
title = {Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00895-23}
}
EUVIMED